Literature DB >> 28259880

Modified Fluorodeoxyglucose Metabolism in Motor Circuitry by Subthalamic Deep Brain Stimulation.

Chunyan Cao1, Huiwei Zhang, Dianyou Li, Shikun Zhan, Jing Zhang, Xiaoxiao Zhang, Chuantao Zuo, Bomin Sun.   

Abstract

BACKGROUND: Adjustment of the motor circuitry has been described in the treatment of Parkinson disease (PD).
OBJECTIVES: To evaluate the modulation of the motor circuitry of PD patients by subthalamic deep brain stimulation (STN DBS) using 18F-fluorodeoxyglucose (FDG) and positron emission tomography (PET).
METHODS: Resting-state brain 18F-FDG PET imaging was performed for 8 PD patients before surgery and also 1 year after STN DBS treatment; changes in regional glucose metabolism were identified. The PD-related pattern (PDRP) of metabolic covariation was also evaluated. In addition, the correlations between glucose metabolism and clinical alleviation were determined.
RESULTS: Pronounced elevations in parietal and occipital glucose metabolism due to STN DBS modification were found; an obvious reduction in caudate, putamen, cerebellum, and frontal cortex glucose metabolism was detected after STN DBS interventions. The alleviation of rigidity correlated with an increment in glucose metabolism in the parietal lobe. STN DBS inhibited the PDRP; the decrease in the PDRP correlated with the inhibition of the glucose metabolism of the caudate and the augmented glucose metabolism of the occipital lobe.
CONCLUSION: STN DBS modulates cortical function through the cortical-striatothalamocortial motor circuitry and cerebellothalamocortical motor circuitry.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Deep brain stimulation; Motor circuitry; Parkinson disease; Positron emission tomography; Subthalamic nucleus

Mesh:

Substances:

Year:  2017        PMID: 28259880     DOI: 10.1159/000455930

Source DB:  PubMed          Journal:  Stereotact Funct Neurosurg        ISSN: 1011-6125            Impact factor:   1.875


  4 in total

Review 1.  Recent Advancement and Clinical Implications of 18FDG-PET in Parkinson's Disease, Atypical Parkinsonisms, and Other Movement Disorders.

Authors:  Cecilia Peralta; Federico Biafore; Tamara Soto Depetris; Maria Bastianello
Journal:  Curr Neurol Neurosci Rep       Date:  2019-06-29       Impact factor: 5.081

2.  Effects of Bilateral Subthalamic Nucleus Stimulation on Depressive Symptoms and Cerebral Glucose Metabolism in Parkinson's Disease: A 18F-Fluorodeoxyglucose Positron Emission Tomography/Computerized Tomography Study.

Authors:  Xiaoxiao Zhang; Huiwei Zhang; Zhengyu Lin; Daniel A N Barbosa; Yijie Lai; Casey H Halpern; Valerie Voon; Dianyou Li; Chencheng Zhang; Bomin Sun
Journal:  Front Neurosci       Date:  2022-06-01       Impact factor: 5.152

3.  Effects of subthalamic deep brain stimulation on striatal metabolic connectivity in a rat hemiparkinsonian model.

Authors:  Nadine Apetz; Elena Kordys; Mascha Simon; Britta Mang; Markus Aswendt; Dirk Wiedermann; Bernd Neumaier; Alexander Drzezga; Lars Timmermann; Heike Endepols
Journal:  Dis Model Mech       Date:  2019-05-24       Impact factor: 5.758

4.  Local and Global Changes in Brain Metabolism during Deep Brain Stimulation for Obsessive-Compulsive Disorder.

Authors:  Juan Carlos Baldermann; Karl Peter Bohn; Jochen Hammes; Canan Beate Schüller; Veerle Visser-Vandewalle; Alexander Drzezga; Jens Kuhn
Journal:  Brain Sci       Date:  2019-08-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.